2023-504350-36-00招募中1 期
Phase I study of MGY825 in patients with lung cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 50
- 试验地点
- 5
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Novartis Pharma Arzneimittel GmbH
Scientific
Novartis Pharma AG
研究点 (5)
Loading locations...
相似试验
进行中（未招募）
不适用
Evaluation of Efficacy of Minimally Invasive Local Therapy for Lung Tumors and Its Impact on Breathing FunctionLung Cancer (Non-Small Cell)Lung Metastases From Any PrimaryNCT07272356Aurimas Macionis68
招募中
1 期
Phase 1 Study of AMG 509 in Subjects With Metastatic Castration-Resistant Prostate CancerMetastatic Castration-Resistant Prostate Cancer (mCRPC)2023-504361-23-00Amgen Inc.41
招募中
3 期
Pre- and post-treatment evaluation of lung function with Xenon-gas enhanced Dual-Energy CT-imaging in patients undergoing radiotherapyRadiation-induced lung injury (radiation fibrosis, radiation pneumonitis)Lung and breast cancer2025-521559-22-00UZ Brussel40
招募中
1 期
Phase 1 Study of PYX-201 in Solid TumorsAdvanced solid tumors2023-509687-14-00Pyxis Oncology Inc.107
尚未招募
1 期
Study of TYK-01054 Capsules in Patients With Advanced Solid TumorsSolid Tumor MalignanciesMalignant Mesothelioma (MM)NCT07282873TYK Medicines, Inc219